Citadel Advisors
ASPX

Citadel Advisors’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Citadel Advisors’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4,279
Closed -$429K – 9459
2015
Q1 		$429K Sell
4,279
-3,473
-45% -$231K ﹤0.01% 5154
2014
Q4 		$407K Buy
+7,752
New +$228K ﹤0.01% 5007

Citadel Advisors's ASPX Position: Q2 2015 in Review

Citadel Advisors sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 4,279 shares — an estimated $429K sold.

Citadel Advisors first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $429K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Citadel Advisors reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Citadel Advisors sold 4,279 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $429K.
  • Citadel Advisors first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Citadel Advisors's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $429K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Citadel Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.